Quantcast

Latest Pioglitazone Stories

2014-09-25 04:22:13

Case Funding Firm adds to funding amounts as Bellwether trials kick into high gear after $9Bil verdict is failed to be dismissed on Takeda post-trial motion. HOUSTON, Sept.

2014-09-23 04:22:04

Actos Lawsuit Help Center Website reports that Takeda and Eli Lilly loses bid to have Judge throw out recent $9Bil Jury verdict. NEW ORLEANS, Sept.

2014-09-03 16:29:02

Takeda Stresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Sept.

2014-08-31 23:01:38

The Firm is evaluating Actos lawsuits on behalf of individuals who developed bladder cancer, allegedly due to long-term use of the Type 2 diabetes drug. New

2014-08-30 23:00:40

In light of the latest development in Actos litigation, The Law Office of Melinda J. Helbock A.P.C.

2014-08-28 23:10:22

Clients Enjoy Healthy Celebratory Meals in Prediabetes Treatment Program Austin, TX (PRWEB) August 28, 2014 PreDiabetes Centers, the nation’s top provider

2014-08-28 12:30:33

No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.

2014-08-26 08:31:41

New JARDIANCE Simple Savings program currently offered in doctors' offices and online RIDGEFIELD, Conn. and INDIANAPOLIS, Aug.

2014-08-11 04:22:07

MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related